Topic: Changes in industrial policy and their effects on industrial growth.
Q6. Identify the key vulnerabilities in India’s pharmaceutical supply chain. Evaluate the impact of government policies in strengthening domestic production. Suggest strategic measures to enhance India’s position in global pharmaceutical markets. (15 M)
Difficulty Level: Medium
Reference: TH
Why the question
With proper coordination between the private sector and academia, the Indian pharma sector’s valuation could grow to ₹10 lakh crore, from its current worth of ₹4 lakh crore, Prime Minister said recently.Key demand of the question
The answer must examine India’s pharmaceutical supply chain weaknesses, critically evaluate how government policies have mitigated these gaps, and suggest forward-looking measures to enhance India’s global market position.Structure of the Answer
Introduction
Briefly highlight India’s role as the “Pharmacy of the World” while mentioning key supply chain challenges that affect self-reliance and global competitiveness.Body
- Key vulnerabilities in India’s pharmaceutical supply chain – Discuss issues such as API dependency, logistics inefficiencies, regulatory delays, and R&D limitations.
- Impact of government policies in strengthening domestic production – Analyze initiatives like the PLI scheme, Bulk Drug Parks, regulatory reforms, and public procurement strategies.
- Strategic measures to enhance global competitiveness – Suggest reforms in API production, regulatory harmonization, R&D investments, trade expansion, and digital health integration.
Conclusion
Conclude with the need for a resilient, innovation-driven pharmaceutical sector, emphasizing policy continuity, global alignment, and investment in technology.
